MGIM
AERI

M&G Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

M&G Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-287,982
Closed -$3.17K – 787
2021
Q3 		$3.17K Buy
287,982
+2,867
+1% +$41.9K 0.01% 461
2021
Q2 		$4.56K Buy
+285,115
New +$4.89M 0.01% 413

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

M&G Investment Management's AERI Position: Q4 2021 in Review

M&G Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 287,982 shares — an estimated $3.17K sold.

M&G Investment Management first reported a position in AERI in Q2 2021 and held it in 2 quarters. The position peaked at $4.56K in Q2 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • M&G Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 287,982 Aerie Pharmaceuticals shares in Q4 2021, an estimated $3.17K.
  • M&G Investment Management first reported a position in Aerie Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Aerie Pharmaceuticals position peaked at $4.56K in Q2 2021.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.